Safety of Moxifloxacin as Shown in Animal and In Vitro Studies

This publication has 18 references indexed in Scilit:

• Ocular Pharmacokinetics of Moxifloxacin After Topical Treatment of Animals and Humans
  Survey of Ophthalmology, 2005
• In Vitro and In Vivo Potency of Moxifloxacin and Moxifloxacin Ophthalmic Solution 0.5%, A New Topical Fluoroquinolone
  Survey of Ophthalmology, 2005
• The Effect of Fourth-Generation Fluoroquinolones Gatifloxacin and Moxifloxacin on Epithelial Healing Following Photorefractive Keratectomy
  American Journal of Ophthalmology, 2005
• A Comparison of Therapeutic Regimens Containing Moxifloxacin 0.5% Ophthalmic Solution and Gatifloxacin 0.3% Ophthalmic Solution for Surgical Prophylaxis in Patients Undergoing LASIK or LASEK
  Journal of Ocular Pharmacology and Therapeutics, 2005
• Comprehensive Evaluation of Ocular Toxicity of Topical Levofloxacin in Rabbit and Primate Models
  Journal of Toxicology- Cutaneous and Ocular Toxicology, 2004
• A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability
  Current Medical Research and Opinion, 2004
• Human aqueous humor levels of oral ciprofloxacin, levofloxacin, and moxifloxacin
  Journal of Cataract & Refractive Surgery, 2001
• Confocal Microscopic Studies of Living Rabbit Cornea Treated with Benzalkonium Chloride
  Cornea, 1992
• Topical fluoroquinolones: Antimicrobial activity andin vitrocorneal epithelial toxicity
  Current Eye Research, 1991
• Pharmacokinetics of topically applied ophthalmic drugs
  Survey of Ophthalmology, 1982